• About BreezyScroll
  • Privacy & Policy
  • Contact Us
Friday, May 23, 2025
BreezyScroll
ADVERTISEMENT
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
No Result
View All Result
BreezyScroll
No Result
View All Result
ADVERTISEMENT

Home  /  Health  /  Major Breakthrough! US FDA approved world’s first RSV vaccine

Major Breakthrough! US FDA approved world’s first RSV vaccine

by Siddhi Vinayak Misra
May 4, 2023
in Health, The US, World
Reading Time: 2 mins read
vaccine

The Food and Drug Administration(FDA) authorized Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine, on Wednesday. This scientific achievement had taken 60 years to come to fruition.

ADVERTISEMENT

According to the New York Post, the pharmaceutical firm GSK created the single-dose shot to protect people aged 60 and up against lower respiratory tract disease caused by RSV.

“Our focus now is to ensure eligible older adults in the US can access the vaccine as quickly as possible and to progress regulatory review in other countries,” Tony Wood, the chief scientific officer at GSK, said in a statement.

RSV, which typically causes mild, cold-like symptoms, can be fatal in elderly persons and young children.

ADVERTISEMENT

According to the Centers for Disease Control and Prevention, the highly contagious virus is responsible for more than 60,000 hospitalizations, 6,000 or more deaths among persons 65 and older in the United States, and 100 to 300 deaths among children under the age of five each year.

The CDC also forecasts that RSV will hospitalize up to 80,000 children under the age of five each year.

Arexvy vaccine reduces risk of severe respiratory illness in clinical trial, according to FDA evaluation

The FDA evaluated data from a clinical trial in which Arexvy was given to 12,500 participants while a placebo was given to the same number. According to the study, immunization reduced the risk of severe RSV-associated LRTD by 94% and RSV-associated LRTD by 83%.

“With this vaccine, Americans over the age of 60, and particularly those with underlying health conditions like COPD, asthma or congestive heart failure, will have a vaccine to help protect against potentially serious outcomes from RSV,” Dr. John Kennedy, the president of the American Medical Group Association, said a statement.

The most commonly reported side effects of the immunization include injection site soreness, tiredness, muscular pain, headaches, and joint stiffness. GSK promises to make RSV immunization available to senior folks ahead of the RSV season, which is slated to begin in the autumn.

Other RSV vaccines are on the way

Researchers expected Pfizer’s RSVpreF vaccine to be approved by the FDA as the first RSV vaccine. The shot, the first RSV vaccine for expectant moms, could be administered to pregnant women in their late second or third trimesters if the agency approves. This is expected to occur in August.

ShareTweetShareSend
ADVERTISEMENT
ADVERTISEMENT

Recent Articles

Adult film star Bonnie Blue, who claimed sex record with 1,057 men, arrested

Adult film star Bonnie Blue, who claimed sex record with 1,057 men, arrested

May 23, 2025
Indigenous Amazon tribe sues US newspapers for portraying members as porn-addicts 

Indigenous Amazon tribe sues US newspapers for portraying members as porn-addicts 

May 23, 2025
Kim

Kim Jong Un calls warship launch failure ‘unpardonable’; death sentence possible?

May 23, 2025
Sun in 8K: Scientists unveil most detailed solar view ever

Sun in 8K: Scientists unveil most detailed solar view ever

May 23, 2025
BreezyScroll Logo

BreezyScroll is a global content platform that provides a unique experience of enhancing the knowledge quotient for its audience by providing the latest news and updates from various categories such as politics, sports, entertainment, technology, and more.
The platform aims to provide a concise and easy-to-read format for its users. BreezyScroll covers news stories from around the world, majorly the United States. The platform was launched in 2021 and has become one of the fastest-growing content companies in the US.

Follow Us

Browse by Category

  • Africa
  • Animals
  • Asia
  • Athletics
  • Australia
  • Auto
  • Basketball
  • Bollywood
  • Brand
  • Breezy Explainer
  • Breezy Feature
  • Breezy Soul
  • Business
  • Canada
  • Chess
  • China
  • Coronavirus
  • Cricket
  • Education
  • Entertainment
  • Environment
  • EPL
  • Europe
  • Exclusive Interview
  • Exclusive Review
  • Football
  • Gaming
  • Health
  • Hollywood
  • India
  • International
  • K Pop
  • Law
  • Lifestyle
  • Middle East
  • Money
  • NFL
  • North America
  • OTT
  • Paris Olympics
  • Pets
  • Press Releases
  • Russia
  • Science
  • South America
  • Space
  • Sports
  • Startup
  • Technology
  • Tennis
  • Tennis
  • The Achievers
  • The US
  • Travel
  • UK
  • UK
  • Uncategorized
  • World
  • WWE

Trending Topics

Afghanistan AI Apple Australia Biden California Canada China Climate Change Coronavirus COVID-19 Donald Trump Elon Musk Featured Florida Google IPL Japan Joe Biden Mars Meta Moon NASA NBA Netflix New York North Korea Ohio Omicron Putin Queen Elizabeth II Russia Russia-Ukraine crisis South Korea SpaceX Taliban Tesla Texas TikTok Trump Twitter UK Ukraine USA Virat Kohli

No Result
View All Result
  • About BreezyScroll
  • Privacy & Policy
  • Contact Us

© 2024 · BreezyScroll.com

No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer

© 2024 · BreezyScroll.com

Go to mobile version